Project Grant K23DA064936
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $722,917 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 15, 2025, to evaluate a novel approach to dispensing methadone in carceral facilities. The research addresses the critical gap in access to medications for opioid use disorder (MOUD) within correctional systems by leveraging a 2024 Substance Abuse and Mental Health Services...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $194,903 to the University of Pennsylvania on April 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year research project extending through March 31, 2030. Principal Investigator Dr. Ashish Thakrar will conduct rigorous research development and clinical investigation into methadone loading dose initiation protocols for hospitalized patients with opioid use disorder...
- Federal Grant Award Summary: PROMOTE Study The University of Pittsburgh received a $488,334 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the Personalized Methadone Treatment (PROMOTE) study, awarded September 30, 2025, with completion targeted for August 31, 2027. This research initiative will adapt and evaluate Implementation Facilitation (IF)—a structured bundle of preparation, implementation, and...
- Federal Project Grant Award Summary Brown University received a $915,478 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective September 1, 2025, through May 31, 2030. The award funds research to evaluate the effectiveness and safety of different methadone treatment strategies for opioid use disorder (OUD) in populations with fentanyl use history. The research addresses a critical gap in evidence-based treatment...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a $1.5M Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a multi-site implementation science study examining the COLAAB (Clinical Organization and Legal Agency Alliance Building) intervention. Effective September 1, 2025, through May 31, 2030, this award supports a large-scale trial designed to improve access to Medications for...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $182,249 Project Grant to The Medical University of South Carolina on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research through June 30, 2029. The award funds the implementation and evaluation of EMPWR (Empowering Pregnant Women Receiving Medications for Opioid Use Disorder), a digitally enhanced clinical intervention designed to improve buprenorphine...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $1,463,994 to the University of Kentucky Research Foundation on September 30, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a randomized, controlled clinical trial advancing non-abstinence treatment outcomes for methamphetamine use disorder (MUD). The project will deliver critical research evidence evaluating how reduced methamphetamine use—rather than complete...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $399,600 under the Drug Use and Addiction Research Programs (CFDA 93.279) to support a five-year mentored research scientist development award (K01) led by Dr. Jason Brian Gibbons at the University of Colorado Anschutz Medical Campus, with performance conducted at Brigham & Women's Hospital in Boston, Massachusetts. The award, dated August 15, 2025, and scheduled for completion by July 31, 2030, funds the...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $439,180 Project Grant (R21) effective September 1, 2025 through August 31, 2027 under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports research investigating dopaminergic neuronal-glial interactions in the striatum, with particular focus on understanding how HIV and methamphetamine (METH) exposure alter dopamine signaling pathways in vivo. The research...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Massachusetts Medical School a Project Grant totaling $144,252 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. This mentoring-focused research award supports Dr. Carreiro's development of training and research programs centered on digital biomarker-driven solutions for opioid use disorder (OUD). The grant funds three...
The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $190,825 to The Regents of the University of Colorado-Denver under the Drug Use and Addiction Research Programs (CFDA 93.279) effective February 1, 2026, with completion scheduled for January 31, 2031. This award supports the development and pilot testing of the Improving Methadone Patient-Centered Treatment (IMPACT) implementation program, designed to increase Opioid Treatment Program (OTP) adoption of new federal methadone treatment regulations enacted in February 2024. The project combines training in qualitative and mixed methods research, partner-engaged implementation science, and trial design and evaluation to address low treatment initiation and retention rates in methadone-based opioid use disorder (OUD) treatment. The IMPACT program will generate research products and implementation guidance to help OTPs transition from highly protocolized clinical workflows to patient-centered care models that leverage new regulatory flexibilities, including increased take-home dosing, greater clinical discretion in initial dosing, and optional individualized counseling. Under the mentorship of an experienced team, the principal investigator will develop evidence-based strategies and evaluation frameworks to support OTP implementation of these practice changes, ultimately contributing to improved health outcomes for individuals with OUD by reducing opioid-related morbidity and mortality.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $190.8k | 1/28/26 |